Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis: ex vivo permeation and in vivo pharmacokinetic studies

References

• Association WM. (2001). World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Bull World Health Organ 79:373
   PubMed Web of Science ®Google Scholar
• Baber N. (1994). International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH). Br J Clin Pharmacol 37:401–4
   PubMed Web of Science ®Google Scholar
• Barry, B.W. (ed.) (1983) Dermatologic formulations: percutaneous absorption. New York: Marcel Dekker
   Google Scholar
• Bondi ML, Fontana G, Carlisi B, Giammona G. (2003). Preparation and characterization of solid lipid nanoparticles containing cloricromene. Drug Deliv 10:245–50
   PubMed Web of Science ®Google Scholar
• Caboi F, Nylander T, Razumas V, et al. (1997). Structural effects, mobility, and redox behavior of vitamin K1 hosted in the monoolein/water liquid crystalline phases. Langmuir 13:5476–83
   Web of Science ®Google Scholar
• Caffrey M. (1987). Kinetics and mechanism of transitions involving the lamellar, cubic, inverted hexagonal, and fluid isotropic phases of hydrated monoacylglycerides monitored by time-resolved X-ray diffraction. Biochemistry 26:6349–63
   PubMed Web of Science ®Google Scholar
• Chantasart D, Li SK, He N, et al. (2004). Mechanistic studies of branched-chain alkanols as skin permeation enhancers. J Pharm Sci 93:762–79
   PubMed Web of Science ®Google Scholar
• Colebatch AN, Marks JL, Edwards CJ. (2011). Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis). Cochrane Database Syst Rev 2011;(11):CD008872
   Google Scholar
• El-Leithy ES, Ibrahim HK, Sorour RM. (2015). In vitro and in vivo evaluation of indomethacin nanoemulsion as a transdermal delivery system. Drug Deliv 22:1010–7
   PubMed Web of Science ®Google Scholar
• Elias PM, Williams ML, Maloney ME, et al. (1984). Stratum corneum lipids in disorders of cornification. Steroid sulfatase and cholesterol sulfate in normal desquamation and the pathogenesis of recessive X-linked ichthyosis. J Clin Invest 74:1414–21
   PubMed Web of Science ®Google Scholar
• Elshafeey AH, Kamel AO, Fathallah MM. (2009). Utility of nanosized microemulsion for transdermal delivery of tolterodine tartrate: ex-vivo permeation and in-vivo pharmacokinetic studies. Pharm Res 26:2446–53
   PubMed Web of Science ®Google Scholar
• Esposito E, Cortesi R, Drechsler M, et al. (2005). Cubosome dispersions as delivery systems for percutaneous administration of indomethacin. Pharm Res 22:2163–73
   PubMed Web of Science ®Google Scholar
• Feczkó T, Tóth J, Dósa G, Gyenis J. (2011). Influence of process conditions on the mean size of PLGA nanoparticles. Chem Eng Process Process Intens 50:846–53
   Web of Science ®Google Scholar
• Ganem-Quintanar A, Quintanar-Guerrero D, Buri P. (2000). Monoolein: a review of the pharmaceutical applications. Drug Dev Ind Pharm 26:809–20
   PubMed Web of Science ®Google Scholar
• Gustafsson J, Ljusberg-Wahren H, Almgren M, Larsson K. (1996). Cubic lipid-water phase dispersed into submicron particles. Langmuir 12:4611–3
   Web of Science ®Google Scholar
• Gustafsson J, Ljusberg-Wahren H, Almgren M, Larsson K. (1997). Submicron particles of reversed lipid phases in water stabilized by a nonionic amphiphilic polymer. Langmuir 13:6964–71
   Web of Science ®Google Scholar
• Hadgraft J. (2001). Skin, the final frontier. Int J Pharm 224:1–18
   PubMed Web of Science ®Google Scholar
• Hans ML, Lowman AM. (2002). Biodegradable nanoparticles for drug delivery and targeting. Curr Opinion Solid State Mat Sci 6:319–27
   Web of Science ®Google Scholar
• Hundekar YR, Saboji JK, Patil SM, Nanjwade BK. (2014). Preparation and evaluation of diclofenac sodium cubosomes for percutaneous administration. wjpps 3:523–39
   Google Scholar
• Hyde S, Andersson S. (1984). A cubic structure consisting of a lipid bilayer forming an infinite periodic minimum surface of the gyroid type in the glycerolmonooleat-water system. Zeitschrift Für Kristallographie-Crystalline Materials 168:213–20
   Web of Science ®Google Scholar
• Jain SK, Chourasia MK, Masuriha R, et al. (2005). Solid lipid nanoparticles bearing flurbiprofen for transdermal delivery. Drug Deliv 12:207–15
   PubMed Web of Science ®Google Scholar
• James E, Reynolds F. 1996. Martindale: The extra pharmacopoeia. London: Royal Pharmaceutical Society
   Google Scholar
• Joge P, Kanchan DK, Sharma P, Gondaliya N. (2013). Effect of nano-filler on electrical properties of PVA-PEO blend polymer electrolyte. IJPAP 51:350–3
   Web of Science ®Google Scholar
• Jones RA. (1999). Etodolac: an overview of a selective COX-2 inhibitor. Inflammopharmacology 7:269–75
   PubMedGoogle Scholar
• Kim YH, Ghanem AH, Higuchi WI. (1992). Model studies of epidermal permeability. Semin Dermatol 11:145–56
   PubMedGoogle Scholar
• Kohli AK, Alpar HO. (2004). Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge. Int J Pharm 275:13–7
   PubMed Web of Science ®Google Scholar
• Korsmeyer RW, Gurny R, Doelker E, et al. (1983). Mechanisms of potassium chloride release from compressed, hydrophilic, polymeric matrices: effect of entrapped air. J Pharm Sci 72:1189–91
   PubMed Web of Science ®Google Scholar
• Kwon TK, Hong SK, Kim J-C. (2012). In vitro skin permeation of cubosomes containing triclosan. J Ind Eng Chem 18:563–7
   Web of Science ®Google Scholar
• Kwon TK, Kim J-C. (2010). Preparation and in vitro skin permeation of cubosomes containing hinokitiol. J Disper Sci Tech 31:1004–9
   Web of Science ®Google Scholar
• Kwon TK, Lee HY, Dai Kim J, et al. (2010). In vitro skin permeation of cubosomes containing water soluble extracts of Korean barberry. Colloid J 72:205–10
   Web of Science ®Google Scholar
• Lampe MA, Williams ML, Elias PM. (1983). Human epidermal lipids: characterization and modulations during differentiation. J Lipid Res 24:131–40
   PubMed Web of Science ®Google Scholar
• Landh T, Larsson K. (1996). Particles, method of preparing said particles and uses thereof. US Patent 5:925
   Google Scholar
• Larsson K. (1989). Cubic lipid-water phases: structures and biomembrane aspects. J Phys Chem 93:7304–14
   Web of Science ®Google Scholar
• Larsson K. (2000). Aqueous dispersions of cubic lipid–water phases. Curr Opin Colloid Interface Sci 5:64–9
   Web of Science ®Google Scholar
• Li S, Ghanem A, Yoneto K, Higuchi W. (1997). Effects of 1-alkyl-2-pyrrolidones on the lipoidal pathway of human epidermal membrane: A comparison with hairless mouse skin. Pharm Res 14:S-303
   PubMed Web of Science ®Google Scholar
• Luzzati V, Vargas R, Mariani P, et al. (1993). Cubic phases of lipid-containing systems. Elements of a theory and biological connotations. J Mol Biol 229:540–51
   PubMed Web of Science ®Google Scholar
• Maibach HI, Smith EW. 2005. Percutaneous penetration enhancers. Boca Raton, FL: CRC Press
   Google Scholar
• Mainardes RM, Evangelista RC. (2005). PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. Int J Pharm 290:137–44
   PubMed Web of Science ®Google Scholar
• Mariani P, Luzzati V, Delacroix H. (1988). Cubic phases of lipid-containing systems. Structure analysis and biological implications. J Mol Biol 204:165–89
   PubMed Web of Science ®Google Scholar
• Meier J, Nüesch E, Schmidt R. (1974). Pharmacokinetic criteria for the evaluation of retard formulations. Eur J Clin Pharmacol 7:429–32
   PubMed Web of Science ®Google Scholar
• Morsi NM, Abdelbary GA, Ahmed MA. (2014). Silver sulfadiazine based cubosome hydrogels for topical treatment of burns: development and in vitro/in vivo characterization. Eur J Pharm Biopharm 86:178–89
   PubMed Web of Science ®Google Scholar
• Muller RH, Radtke M, Wissing SA. (2002). Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 54 Suppl 1:S131–55
   PubMed Web of Science ®Google Scholar
• Norlen L, Al-Amoudi A. (2004). Stratum corneum keratin structure, function, and formation: the cubic rod-packing and membrane templating model. J Invest Dermatol 123:715–32
   PubMed Web of Science ®Google Scholar
• Pal SL, Jana U, Manna PK, et al. (2011). Nanoparticle: An overview of preparation and characterization. J Appl Pharm Sci 1:228–34
   Google Scholar
• Pan X, Han K, Peng X, et al. (2013). Nanostructured cubosomes as advanced drug delivery system. Curr Pharm Des 19:6290–7
   PubMed Web of Science ®Google Scholar
• Patrick TS. 2009. Cubosomes: bicontinuous liquid crystalline nanoparticles. dekker encyclopedia of nanoscience and nanotechnology. New York: Taylor & Francis
   Google Scholar
• Peppas NA. (1985). Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv 60:110–1
   PubMedGoogle Scholar
• Rattanapak T, Young K, Rades T, Hook S. (2012). Comparative study of liposomes, transfersomes, ethosomes and cubosomes for transcutaneous immunisation: characterisation and in vitro skin penetration. J Pharm Pharmacol 64:1560–9
   PubMed Web of Science ®Google Scholar
• Raykar PV, Fung MC, Anderson BD. (1988). The role of protein and lipid domains in the uptake of solutes by human stratum corneum. Pharm Res 5:140–50
   PubMed Web of Science ®Google Scholar
• Rizwan SB, Hanley T, Boyd BJ, et al. (2009). Liquid crystalline systems of phytantriol and glyceryl monooleate containing a hydrophilic protein: characterisation, swelling and release kinetics. J Pharm Sci 98:4191–204
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Panyam J, Prabha S, Labhasetwar V. (2002). Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release 82:105–14
   PubMed Web of Science ®Google Scholar
• Salama AH, Mahmoud AA, Kamel R. (2016). A novel method for preparing surface-modified fluocinolone acetonide loaded PLGA nanoparticles for ocular use: in vitro and in vivo evaluations. AAPS PharmSciTech 17:1159–72
   PubMed Web of Science ®Google Scholar
• Salama HA, Mahmoud AA, Kamel AO, et al. (2012a). Brain delivery of olanzapine by intranasal administration of transfersomal vesicles. J Liposome Res 22:336–45
   PubMed Web of Science ®Google Scholar
• Salama HA, Mahmoud AA, Kamel AO, et al. (2012b). Phospholipid based colloidal poloxamer–nanocubic vesicles for brain targeting via the nasal route. Colloids Surf B Biointerf 100:146–54
   PubMed Web of Science ®Google Scholar
• Spicer PT, Small WB, Lynch MLI, Burns JL. (2002). Dry powder precursors of “soft” cubic liquid crystalline nanoparticles (cubosomes). J Nanopart Res 4:297–311
   Web of Science ®Google Scholar
• Subongkot T, Pamornpathomkul B, Rojanarata T, et al. (2014). Investigation of the mechanism of enhanced skin penetration by ultradeformable liposomes. Int J Nanomed 9:3539–50
   PubMed Web of Science ®Google Scholar
• Xu Q, Crossley A, Czernuszka J. (2009). Preparation and characterization of negatively charged poly(lactic-co-glycolic acid) microspheres. J Pharm Sci 98:2377–89
   PubMed Web of Science ®Google Scholar
• Yaghmur A, Glatter O. (2009). Characterization and potential applications of nanostructured aqueous dispersions. Adv Colloid Interface Sci 147-148:333–42
   PubMed Web of Science ®Google Scholar
• Yapar EA, Ýnal Ö. (2012). Poly (ethylene oxide)–poly (propylene oxide)-based copolymers for transdermal drug delivery: An overview. Trop J Pharm Res 11:855–66
   Web of Science ®Google Scholar